Primer set for detecting cashew nut, and method for detecting cashew nut using the same

A primer set for detecting cashew nuts amplifies a specific region of the ITS-1 ribosomal RNA gene, addressing sensitivity and specificity issues in existing methods, enabling accurate and efficient detection of cashew nuts in food products.

JP2024159509APending Publication Date: 2024-11-08HOUSE FOODS GRP INC
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2024035327
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-28
Filing Date
2024-03-07
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing methods for detecting cashew nuts in food products lack sensitivity and specificity, particularly in distinguishing cashew nuts from closely related species and are not robust against food processing, making accurate allergen labeling challenging.

Method used

A primer set comprising specific base sequences and a probe designed to amplify a region of the ITS-1 ribosomal RNA gene of cashew nuts, capable of detecting as little as 250 fg of cashew nut DNA with a fragment length of 150 bp or less, while avoiding amplification of related species like mango, pink pepper, and pistachio, using common PCR conditions.

Benefits of technology

The primer set enables highly sensitive and specific detection of cashew nuts, even in processed food samples, with robustness against DNA fragmentation and the ability to be used under the same conditions as other allergen detection methods, reducing the effort required for analysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024159509000001_ABST
    Figure 2024159509000001_ABST
Patent Text Reader

Abstract

To provide novel means for detecting a cashew nut.SOLUTION: A primer set for detecting a cashew nut includes: a primer A including a base sequence A1 or a homologous sequence or a partial sequence thereof; and a primer B including a base sequence B1 or a homologous sequence or a partial sequence thereof, where the base sequences A1 and B1 are a combination of specific amino acid sequences.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a primer set that can be used to detect cashew nuts, which are a food allergen in foods and beverages, and a method for detecting cashew nuts using the same. [Background technology]

[0002] Cashew nuts (Anacardium occidentale) (also called cashew or cashew nut tree) is a plant belonging to the genus Anacardium (Anacardiaceae) of the family Anacardiaceae, and its kernel is edible as a nut known as "cashew nuts". Hereinafter, in this specification, "cashew nuts" refers to the kernel that is edible as a nut, and "cashew nut plant" refers to Anacardium occidentale.

[0003] Cashew nuts are one of the food allergens that can cause allergies, and in some patients they can cause severe anaphylactic shock symptoms.

[0004] Cashew nuts are currently one of the 20 food allergens recommended for allergen labeling in Japan. The number of people with allergies caused by cashew nuts is on the rise. Among nuts, cashew nuts are the second most common cause of serious cases after walnuts, which are required to be labeled as allergens. For this reason, it is possible that allergen labeling for cashew nuts will become mandatory in the future.

[0005] Non-Patent Document 1 describes a primer-probe set for detecting cashew nuts by real-time PCR. The primer set described in Non-Patent Document 1 amplifies the Internal Transcribed Spacer (ITS) region of cashew DNA. Non-Patent Document 1 describes that 0.1 mg of cashew nuts contained in a mixture of 1 kg of wheat flour and cashew nuts could be detected, and that 48 species of plants and 4 species of animals were not detected.

[0006] Patent Document 1 describes a primer set for detecting cashew nuts by PCR. It also describes that the lower limit of detection sensitivity with the primer set was 1 pg / μL in terms of the concentration of cashew nut DNA during the PCR reaction, and that the primer set did not amplify DNA of pistachio, mango, and pink pepper, which are closely related species of the cashew nut plant.

[0007] Meanwhile, Patent Document 2 discloses a primer set that can detect wheat, buckwheat, and peanuts, which are allergens contained in foods and beverages, by real-time PCR under common PCR conditions. [Prior art documents] [Patent documents]

[0008] [Patent Document 1] JP 2016-187329 A [Patent Document 2] JP 2016-101142 A [Non-patent literature]

[0009] [Non-Patent Document 1] Lopez-Calleja,IM, et al,Food Science and Technology 62(2015)233-241 Summary of the Invention [Problem to be solved by the invention]

[0010] One or more embodiments of the present invention provide a new primer set for detecting cashew nuts and a method for detecting cashew nuts using the same. [Means for solving the problem]

[0011] This specification discloses one or more of the following embodiments of the present invention. (1) A primer set for detecting cashew nuts, (A1) base sequence A1, (A2) a base sequence A2 having an identity of 80% or more but less than 100% with the base sequence A1, and a partial base sequence having NA consecutive bases (NA is an integer of 1 or more) from the 3'-terminal base is identical to a partial base sequence of the base sequence A1 having NA consecutive bases from the 3'-terminal base, and (A3) A base sequence A3, which is a partial base sequence of 8 or more consecutive bases from the 3'-terminal base of the base sequence A1 or A2. and a primer A comprising an oligonucleotide comprising at its 3' end a base sequence A selected from the following: (B1) base sequence B1, (B2) a base sequence B2 having an identity of 80% or more but less than 100% with the base sequence B1, and a partial base sequence of a number NB of consecutive bases (NB is an integer of 1 or more) from the 3'-terminal base being identical to a partial base sequence of the number NB of consecutive bases from the 3'-terminal base of the base sequence B1; and (B3) a partial base sequence of 8 or more consecutive bases from the 3'-terminal base of the base sequence B1 or B2; Primer B comprising an oligonucleotide containing at its 3' end a base sequence B selected from Including, The base sequence A1 and the base sequence B1 are the following combination: (S13) the base sequence A1 is the base sequence shown in SEQ ID NO: 3, and the base sequence B1 is the base sequence shown in SEQ ID NO: 8; (S14) the base sequence A1 is the base sequence shown in SEQ ID NO: 3, and the base sequence B1 is the base sequence shown in SEQ ID NO: 9; (S25) the base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO: 9; (S26) the base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO: 10; (S27) The base sequence A1 is a base sequence shown in SEQ ID NO: 5, and the base sequence B1 is a base sequence shown in SEQ ID NO: 11. (S29) the base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO: 13; (S30) the base sequence A1 is the base sequence shown in SEQ ID NO: 6, and the base sequence B1 is the base sequence shown in SEQ ID NO: 9; (S31) the base sequence A1 is the base sequence shown in SEQ ID NO: 6, and the base sequence B1 is the base sequence shown in SEQ ID NO: 10; (S32) the base sequence A1 is the base sequence shown in SEQ ID NO: 6, and the base sequence B1 is the base sequence shown in SEQ ID NO: 11; (S35) the base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO: 11; (S36) the base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO: 12; (S37) The base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO: 13. Either Primer set. (2) The primer set according to (1), wherein the base sequence A1 and the base sequence B1 are the combination (S25), (S26), (S27), (S29), (S31), (S32), (S35), (S36) or (S37). (3) The primer set according to (2), wherein the base sequence A1 and the base sequence B1 are the combination (S35) or (S36). (4)(C1) nucleotide sequence C1, (C2) a base sequence C2 having an identity of 80% or more but less than 100% with the base sequence C1 and a partial base sequence of consecutive bases NC (NC is an integer of 3 or more) identical to a partial base sequence of consecutive bases NC in the base sequence C1; (C3) a base sequence C3 which is a partial base sequence of 8 or more consecutive bases of the base sequence C1 or C2; and (C4) a base sequence C4 complementary to the base sequence C1, C2 or C3 The method further comprises a probe C comprising an oligonucleotide comprising a base sequence C selected from when the base sequence A1 and the base sequence B1 are the combination (S25), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, when the base sequence A1 and the base sequence B1 are the combination (S26), the base sequence C1 is the base sequence shown in SEQ ID NO: 14 or 15, when the base sequence A1 and the base sequence B1 are the combination (S27), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, 15 or 16, when the base sequence A1 and the base sequence B1 are the combination (S29), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, 15, 16 or 17, when the base sequence A1 and the base sequence B1 are the combination (S31), the base sequence C1 is the base sequence shown in SEQ ID NO: 15, when the base sequence A1 and the base sequence B1 are the combination (S32), the base sequence C1 is the base sequence shown in SEQ ID NO: 15 or 16, When the base sequence A1 and the base sequence B1 are the combination (S35), (S36) or (S37), the base sequence C1 is the base sequence shown in SEQ ID NO: 16 or 17. The primer set described in (2). (5) The primer set according to (4), wherein the base sequence A1 and the base sequence B1 are the combination (S35), (S36) or (S37), and the base sequence C1 is the base sequence shown in SEQ ID NO: 16 or 17. (6) The primer set according to (5), wherein the base sequence A1 and the base sequence B1 are the combination (S35) or (S36), and the base sequence C1 is the base sequence shown in SEQ ID NO: 17. (7) A method for detecting cashew nuts in a sample, comprising: (1) performing a nucleic acid amplification reaction using DNA derived from the sample as a template and the primer set described in (1); and Detecting an amplification product from the nucleic acid amplification reaction. The method includes: (8) A method for detecting cashew nuts in a sample, comprising: (4) performing a nucleic acid amplification reaction using DNA derived from the sample as a template and the primer set described in (1); and detecting the binding between the amplification product of the nucleic acid amplification reaction and the probe C; The method includes: (9) The method according to (7) or (8), wherein the sample is a food or beverage sample. Effect of the Invention

[0012] According to one or more embodiments of the present invention, there is provided a new primer set for detecting cashew nuts and a method for detecting cashew nuts using the same. [Brief description of the drawings]

[0013] [Figure 1] FIG. 1 shows the results of analysis of PCR amplification products in selections 4 and 5. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] <1. Purpose> It is desirable for the primer set and the detection method using the same according to one or more embodiments of the present invention to satisfy the following requirements.

[0015] (Detection target) Other commonly recognised edible plants belonging to the Anacardiaceae family besides the cashew nut plant are mango (Mangifera indica), pink pepper (Schinus molle), pistachio (Pistacia vera) and sumac (Rhus coriaria).

[0016] Therefore, one or more embodiments of the present invention aim to provide a primer set capable of amplifying the DNA of cashew nuts without amplifying the DNA of mango, pink pepper, pistachio, and sumac, and a method for detecting cashew nuts using the same. Cashew nuts are produced in Brazil, the country of origin, as well as India and Nigeria.

[0017] (sensitivity) For the detection of allergens, it is desirable to be able to detect a concentration equivalent to 1 μg cashew nut protein / g sample (=1 ppm). Since the protein content of cashew nut kernels is 19.8 g / 100 g (Food Composition Database), 1 μg cashew nut protein / g sample is equivalent to 5.1 μg cashew nuts / g sample. Assuming that DNA can be recovered at the same yield from the sample and cashew nuts, 5.1 μg cashew nuts / g sample is equivalent to 250 fg cashew nut DNA / 50 ng sample DNA.

[0018] Therefore, it is desirable that the primer set and detection method according to one or more embodiments of the present invention are capable of amplifying cashew nut DNA present at a concentration of 250 fg cashew nut DNA / 50 ng sample DNA.

[0019] (Robustness) DNA derived from ingredients contained in food and beverages may be fragmented during processing. Therefore, when amplifying cashew nut DNA using a nucleic acid amplification reaction and detecting the presence or absence of an amplified product, the shorter the length of the amplified target DNA fragment, the more stable the detection, without being affected by processing.

[0020] Therefore, the primer set and detection method according to one or more embodiments of the present invention are preferably capable of amplifying a target sequence contained in cashew nut DNA and having a fragment length of 150 bp or less.

[0021] (Comparison with conventional technology) Non-Patent Document 1 and Patent Document 1 describe a method of amplifying the base sequence of DNA specific to cashew nuts by a nucleic acid amplification reaction using a specific primer set and detecting the presence or absence of an amplified product. However, no method that satisfies the above requirements is disclosed. For example, the method described in Non-Patent Document 1 does not confirm the presence or absence of detection in closely related species other than pistachios, so it is unclear whether it is possible to specifically detect cashew nuts.

[0022] (PCR conditions) Patent Document 2 describes that wheat, buckwheat and peanut DNA are detected by real-time PCR under common PCR conditions (specifically, Condition 1 shown in the Examples). The common PCR conditions for amplifying wheat, buckwheat and peanut DNA described in Patent Document 2 have a relatively short cycle number. If cashew nut DNA can be amplified under the PCR conditions described in Patent Document 2, it will be possible for users to detect the presence or absence of cashew nut, wheat, buckwheat and peanut DNA with simple operations.

[0023] Therefore, it is further desirable that the primer set and detection method according to one or more embodiments of the present invention are capable of amplifying cashew nut DNA under common PCR conditions for amplifying wheat, buckwheat and peanut DNA as described in Patent Document 2.

[0024] <2. Primer set for detecting cashew nuts> According to one or more embodiments of the present invention, a primer set for detecting cashew nuts comprises: (A1) base sequence A1, (A2) a base sequence A2 having an identity of 80% or more but less than 100% with the base sequence A1, and a partial base sequence having NA consecutive bases (NA is an integer of 1 or more) from the 3'-terminal base is identical to a partial base sequence of the base sequence A1 having NA consecutive bases from the 3'-terminal base, and (A3) A base sequence A3, which is a partial base sequence of 8 or more consecutive bases from the 3'-terminal base of the base sequence A1 or A2. and a primer A comprising an oligonucleotide comprising at its 3' end a base sequence A selected from the following: (B1) base sequence B1, (B2) a base sequence B2 having an identity of 80% or more but less than 100% with the base sequence B1, and a partial base sequence of a number NB of consecutive bases (NB is an integer of 1 or more) from the 3'-terminal base being identical to a partial base sequence of the number NB of consecutive bases from the 3'-terminal base of the base sequence B1; and (B3) a partial base sequence of 8 or more consecutive bases from the 3'-terminal base of the base sequence B1 or B2; Primer B comprising an oligonucleotide containing at its 3' end a base sequence B selected from Including, The base sequence A1 and the base sequence B1 are the following combination: (S13) the base sequence A1 is the base sequence shown in SEQ ID NO: 3, and the base sequence B1 is the base sequence shown in SEQ ID NO: 8; (S14) the base sequence A1 is the base sequence shown in SEQ ID NO: 3, and the base sequence B1 is the base sequence shown in SEQ ID NO: 9; (S25) the base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO: 9; (S26) the base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO: 10; (S27) The base sequence A1 is a base sequence shown in SEQ ID NO: 5, and the base sequence B1 is a base sequence shown in SEQ ID NO: 11. (S29) the base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO: 13; (S30) the base sequence A1 is the base sequence shown in SEQ ID NO: 6, and the base sequence B1 is the base sequence shown in SEQ ID NO: 9; (S31) the base sequence A1 is the base sequence shown in SEQ ID NO: 6, and the base sequence B1 is the base sequence shown in SEQ ID NO: 10; (S32) the base sequence A1 is the base sequence shown in SEQ ID NO: 6, and the base sequence B1 is the base sequence shown in SEQ ID NO: 11; (S35) the base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO: 11; (S36) the base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO: 12; (S37) The base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO: 13. The present invention is characterized in that the above-mentioned

[0025] The primer set according to the present embodiment is designed to amplify a part of the ITS (Internal Transcribed Spacer)-1 region of the ribosomal RNA gene derived from cashew nuts. The DNA base sequence including ITS-1 and ITS-2 of the ribosomal RNA gene of cashew nuts is published under GenBank Accession No. AB071690.1 (SEQ ID NO: 18) and KF664192.1 (SEQ ID NO: 19).

[0026] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S13), a DNA fragment including a 90 bp region of the ITS-1 region is generated as an amplification product.

[0027] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S14), a DNA fragment including a 131 bp region of the ITS-1 region is generated as an amplification product.

[0028] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S25), a DNA fragment including a 67 bp region of the ITS-1 region is generated as an amplification product.

[0029] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S26), a DNA fragment including a 91 bp region of the ITS-1 region is generated as an amplification product.

[0030] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S27), a DNA fragment including a 119 bp region of the ITS-1 region is generated as an amplification product.

[0031] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S29), a DNA fragment including a 145 bp region of the ITS-1 region is generated as an amplification product.

[0032] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S30), a DNA fragment including a 54 bp region of the ITS-1 region is generated as an amplification product.

[0033] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S31), a DNA fragment including a 78 bp region of the ITS-1 region is generated as an amplification product.

[0034] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is (S32), a DNA fragment including a 106 bp region of the ITS-1 region is generated as an amplification product.

[0035] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S35), a DNA fragment including a 58 bp region of the ITS-1 region is generated as an amplification product.

[0036] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is (S36), a DNA fragment including a 76 bp region of the ITS-1 region is generated as an amplification product.

[0037] When a nucleic acid amplification reaction of cashew nut-derived DNA is performed using the primer set of this embodiment in which the combination of the base sequence A1 and the base sequence B1 is as described above (S37), a DNA fragment including an 84 bp region of the ITS-1 region is generated as an amplification product.

[0038] In both cases, the fragment lengths of the amplified products were significantly shorter than 150 bp, allowing for highly robust detection that is less affected by food and beverage processing.

[0039] The primer set according to this embodiment makes it possible to specifically detect cashew nuts with high sensitivity.

[0040] In the above (A2) and (B2) and the below-described (C2), the identity value indicates a value calculated by using software (e.g., BLAST) that calculates the identity between multiple base sequences with default settings. The identity value of a base sequence is calculated by calculating the number of matching bases when a pair of base sequences are aligned so as to maximize the degree of identity, and is calculated as the ratio of the number of matching bases to the total number of bases of the compared base sequences. Here, when there is a gap, the total number of bases mentioned above is the number of bases counted with one gap as one base. For details of the method of determining identity, see, for example, Altschul et al., J. Mol. Biol. 215, 403-410, 1990.

[0041] In the above (A2) and (B2), the identity is more preferably 85% or more, more preferably 90% or more, more preferably 95% or more, more preferably 97% or more, more preferably 98% or more, more preferably 99% or more.

[0042] Next, more preferred embodiments of primer A and primer B will be described.

[0043] The oligonucleotide in primer A may contain base sequence A selected from base sequence A1, base sequence A2, and base sequence A3 at the 3'-end, and may further contain another base sequence added to the 5'-end side of base sequence A, or may consist of only base sequence A. The length (number of bases) of the oligonucleotide in primer A is not particularly limited, but is usually 30 bases or less, preferably 25 bases or less, more preferably 20 bases or less, and more preferably 18 bases or less. The number of bases of the other base sequence added to the 5'-end side of base sequence A is, for example, 10 or less, preferably 5 or less, and more preferably 3 or less.

[0044] Primer A may consist of only the oligonucleotide, or may be the oligonucleotide to which other elements such as a label, a tag, etc. are linked. The other elements may be linked to any position of the oligonucleotide, but it is particularly preferred that they are linked to the 5' end of the oligonucleotide.

[0045] The base sequence A1 is any one of the base sequence shown in SEQ ID NO:3, the base sequence shown in SEQ ID NO:5, the base sequence shown in SEQ ID NO:6, and the base sequence shown in SEQ ID NO:7.

[0046] The base sequence A2 has an identity of 80% or more but less than 100% with the base sequence A1. A more preferred range of identity is as described above. The base sequence A2 is a base sequence in which preferably 1, 2 or 3 bases, more preferably 1 or 2 bases, and particularly preferably 1 base, are substituted, deleted or added to the base sequence A1. Furthermore, the base sequence A2 has a partial base sequence of NA consecutive bases (NA is an integer of 1 or more) from the 3'-terminal base, which is identical to the partial base sequence of the base sequence A1 having NA consecutive bases from the 3'-terminal base. Here, NA may be 1 or more, but is preferably 2 or more, more preferably 3 or more, more preferably 5 or more, more preferably 8 or more, more preferably 10 or more, more preferably 12 or more, and more preferably 13 or more. Furthermore, when the number of bases in the base sequence A1 is MA, NA can be preferably MA-1 or less, more preferably MA-2 or less, more preferably MA-3 or less, more preferably MA-5 or less, and more preferably MA-8 or less.

[0047] The base sequence A3 is a partial base sequence of the base sequence A1 or A2, which is 8 or more consecutive bases from the 3'-terminal base, preferably 10 or more consecutive bases, more preferably 12 or more consecutive bases, more preferably 13 or more consecutive bases, more preferably 14 or more consecutive bases. Since the base sequence A3 is a partial base sequence of the base sequence A1 or A2, the number of bases of the base sequence A3 is smaller by one or more bases than the number of bases of the base sequence A1 or A2.

[0048] The base sequence A is more preferably selected from the base sequence A1 and the base sequence A2.

[0049] The oligonucleotide in primer B may contain base sequence B selected from base sequence B1, base sequence B2, and base sequence B3 at the 3'-terminus, and may further contain another base sequence added to the 5'-terminus side of base sequence B, or may consist of only base sequence B. The length (number of bases) of the oligonucleotide in primer B is not particularly limited, but is usually 35 bases or less, preferably 30 bases or less, and more preferably 27 bases or less. The number of bases of the other base sequence added to the 5'-terminus side of base sequence B is, for example, 10 or less, preferably 5 or less, and more preferably 3 or less.

[0050] Primer B may consist of only the oligonucleotide, or may be the oligonucleotide to which other elements such as a label, a tag, etc. are linked. The other elements may be linked to any position of the oligonucleotide, but it is particularly preferred that they are linked to the 5' end of the oligonucleotide.

[0051] The base sequence B1 is selected from the base sequence shown in SEQ ID NO: 8, the base sequence shown in SEQ ID NO: 9, the base sequence shown in SEQ ID NO: 10, the base sequence shown in SEQ ID NO: 11, the base sequence shown in SEQ ID NO: 12, and the base sequence shown in SEQ ID NO: 13, so that its combination with the base sequence A1 is any of the combinations (S13), (S14), (S25), (S26), (S27), (S29), (S30), (S31), (S32), (S35), (S36) or (S37).

[0052] The base sequence B2 has an identity of 80% or more but less than 100% with the base sequence B1. A more preferred range of identity is as described above. The base sequence B2 is a base sequence in which preferably 1, 2 or 3 bases, more preferably 1 or 2 bases, and particularly preferably 1 base, are substituted, deleted or added to the base sequence B1. Furthermore, the base sequence B2 has a partial base sequence of NB consecutive bases (NB is an integer of 1 or more) from the 3'-terminal base, which is identical to the partial base sequence of NB consecutive bases from the 3'-terminal base of the base sequence B1. Here, NB may be 1 or more, but is preferably 2 or more, more preferably 3 or more, more preferably 5 or more, more preferably 8 or more, more preferably 10 or more, more preferably 12 or more, and more preferably 13 or more. Furthermore, when the number of bases of the base sequence B1 is MB, NB can be preferably MB-1 or less, more preferably MB-2 or less, more preferably MB-3 or less, more preferably MB-5 or less, and more preferably MB-8 or less.

[0053] When the base sequence B1 is the base sequence shown in SEQ ID NO: 8 or the base sequence shown in SEQ ID NO: 10, the base sequence B3 is a partial base sequence of 8 or more consecutive bases, preferably 10 or more consecutive bases, more preferably 12 or more consecutive bases, more preferably 14 or more consecutive bases, from the 3'-terminal base of the base sequence B1 or B2. When the base sequence B1 is the base sequence shown in SEQ ID NO: 9, the base sequence B3 is a partial base sequence of 8 or more consecutive bases, preferably 10 or more consecutive bases, more preferably 12 or more consecutive bases, more preferably 14 or more consecutive bases, more preferably 16 or more consecutive bases, more preferably 18 or more consecutive bases, more preferably 20 or more consecutive bases, more preferably 22 or more consecutive bases, from the 3'-terminal base of the base sequence B1 or B2. Since the base sequence B3 is a partial base sequence of the base sequence B1 or B2, the number of bases in the base sequence B3 is smaller than the number of bases in the base sequence B1 or B2 by one or more bases.

[0054] The base sequence B is more preferably selected from the base sequence B1 and the base sequence B2.

[0055] The primer set for detecting cashew nuts, which includes the above-mentioned primer A and primer B, may further include a probe. The probe may include an oligonucleotide that can bind (hybridize) under stringent conditions to at least a partial region of a target sequence in an amplification product amplified by a nucleic acid amplification reaction using primer A and primer B.

[0056] The probe may consist of only an oligonucleotide, or may be a fluorescent substance (e.g., FAM) attached to the oligonucleotide. TM , TET TM , V.I.C. TM , HEX TM , N.E.D.TM , PET, etc.) and / or a quencher (e.g., TAMRA TM , ROX TM , MGB, BHQ(Black Hole Quencher) TM , BBQ (Blackberry Quencher) TM Such labeled probes may be labeled with TaqMan TM Preferably, a fluorescent substance is linked to one end of an oligonucleotide, and a quencher is linked to the other end.

[0057] The primer set according to this embodiment is more preferably the base sequence A1 and the base sequence B1 are the combination (S25), (S26), (S27), (S29), (S31), (S32), (S35), (S36) or (S37); As a probe, (C1) base sequence C1; (C2) a base sequence C2 having an identity of 80% or more but less than 100% with the base sequence C1 and a partial base sequence of consecutive bases NC (NC is an integer of 3 or more) identical to a partial base sequence of consecutive bases NC in the base sequence C1; (C3) a base sequence C3 which is a partial base sequence of 8 or more consecutive bases of the base sequence C1 or C2; and (C4) a base sequence C4 complementary to the base sequence C1, C2 or C3 The method further comprises a probe C comprising an oligonucleotide comprising a base sequence C selected from when the base sequence A1 and the base sequence B1 are the combination (S25), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, when the base sequence A1 and the base sequence B1 are the combination (S26), the base sequence C1 is the base sequence shown in SEQ ID NO: 14 or 15, when the base sequence A1 and the base sequence B1 are the combination (S27), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, 15 or 16, when the base sequence A1 and the base sequence B1 are the combination (S29), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, 15, 16 or 17, when the base sequence A1 and the base sequence B1 are the combination (S31), the base sequence C1 is the base sequence shown in SEQ ID NO: 15, when the base sequence A1 and the base sequence B1 are the combination (S32), the base sequence C1 is the base sequence shown in SEQ ID NO: 15 or 16, When the base sequence A1 and the base sequence B1 are the combination (S35), (S36) or (S37), the base sequence C1 is the base sequence shown in SEQ ID NO:16 or 17.

[0058] The oligonucleotide in the probe C may contain at least a part of the base sequence C selected from the base sequence C1, the base sequence C2, the base sequence C3, and the base sequence C4, and may further contain other base sequences added to the 3'-end side and / or the 5'-end side (preferably only the 5'-end side) of the base sequence C, or may consist of only the base sequence C. The length (number of bases) of the oligonucleotide in the probe C is not particularly limited, but is usually 35 bases or less, preferably 30 bases or less, more preferably 25 bases or less, and more preferably 20 bases or less. The number of bases of the other base sequences added to the 3'-end side and / or the 5'-end side of the base sequence C is, for example, 10 or less, preferably 5 or less, more preferably 3 or less in total. The probe C may consist of only the oligonucleotide, but preferably the fluorescent substance and / or the quencher is linked to the oligonucleotide.

[0059] The base sequence C2 has an identity of 80% or more but less than 100% with the base sequence C1. A more preferred range of identity is as described above. The base sequence C2 is a base sequence in which preferably 1, 2 or 3 bases, more preferably 1 or 2 bases, and particularly preferably 1 base, are substituted, deleted or added to the base sequence C1. Furthermore, the base sequence C2 has a partial base sequence of consecutive bases NC (NC is an integer of 3 or more) that is identical to a partial base sequence of consecutive bases NC in the base sequence C1. Here, NC may be 3 or more, but is preferably 4 or more, more preferably 5 or more, more preferably 8 or more, more preferably 10 or more, more preferably 12 or more, and more preferably 13 or more. Furthermore, when the number of bases in the base sequence C1 is MC, NC can be preferably MC-1 or less, more preferably MC-2 or less, more preferably MC-3 or less, more preferably MC-5 or less, and more preferably MC-8 or less.

[0060] When the base sequence C1 is the base sequence shown in SEQ ID NO: 14, the base sequence C3 is a partial base sequence of 8 or more consecutive bases, preferably 10 or more consecutive bases, more preferably 12 or more consecutive bases, more preferably 14 or more consecutive bases, more preferably 15 or more consecutive bases, of the base sequence C1 or C2. When the base sequence C1 is the base sequence shown in SEQ ID NO: 15, the base sequence C3 is a partial base sequence of 8 or more consecutive bases, preferably 10 or more consecutive bases, more preferably 12 or more consecutive bases, more preferably 14 or more consecutive bases, more preferably 17 or more consecutive bases, of the base sequence C1 or C2. When the base sequence C1 is the base sequence shown in SEQ ID NO: 16 or 17, the base sequence C3 is a partial base sequence of 8 or more consecutive bases, preferably 10 or more consecutive bases, more preferably 12 or more consecutive bases, more preferably 14 or more consecutive bases, of the base sequence C1 or C2. Since the base sequence C3 is a partial base sequence of the base sequence C1 or C2, the number of bases of the base sequence C3 is one or more bases smaller than the number of bases of the base sequence C1 or C2.

[0061] The base sequence C4 is a complementary base sequence to the base sequence C1, C2 or C3.

[0062] The base sequence C is more preferably selected from the base sequence C1, the base sequence C2 and the base sequence C3, and particularly preferably selected from the base sequence C1 and the base sequence C2.

[0063] The oligonucleotides contained in the above primer A, primer B and / or probe can be synthesized by a method known in the art for synthesizing oligonucleotides, such as the phosphotriethyl method or the phosphodiester method, using a commonly used automatic DNA synthesizer.

[0064] In the primer set according to one or more embodiments of the present invention, each of the above elements may be contained in a separate container, or each element may be contained in a container for one use and for each amount to be used. Alternatively, each element may be contained in a single container in an amount sufficient for multiple uses (a user can take out and use the amount required for one use). Each of the above elements may be contained in a container in a dry form, or in a form dissolved in an appropriate solvent.

[0065] The primer set according to one or more embodiments of the present invention may further comprise one or more elements selected from a dNTP mix, a DNA polymerase, SYBR® Green I, magnesium chloride, and instructions for use.

[0066] The primer set according to one or more embodiments of the present invention may be combined with one or more other primer sets for detecting food allergens to form a kit for detecting food allergens.

[0067] The one or more other primer sets for detecting the food allergens include one or more primer sets for detecting food allergens such as wheat, buckwheat, peanuts, and walnuts. As a primer set for detecting wheat, a primer set for detecting buckwheat, and / or a primer set for detecting peanuts, the primer set described in Patent Document 2 (JP 2016-101142 A) is preferable. As a primer set for detecting walnuts, the primer set described in JP 2021-185820 A is preferable. The primer set according to one or more embodiments of the present invention is capable of amplifying and detecting cashew nut DNA by a PCR method under common conditions for detecting wheat, buckwheat, peanuts, and walnuts. Therefore, by using the primer set according to one or more embodiments of the present invention, it is possible to detect cashew nuts under PCR conditions for detecting wheat, buckwheat, peanuts, and / or walnuts. Therefore, the detection of wheat, buckwheat, peanuts, walnuts, and cashew nuts can be carried out simultaneously under the same conditions, and the effort of analysis can be reduced.

[0068] <3. Method for detecting cashew nuts in a sample> According to one or more embodiments of the present invention, a method for detecting cashew nuts in a sample comprises the steps of: carrying out a nucleic acid amplification reaction using the DNA derived from the sample as a template and the primer set for detecting cashew nuts; and Detecting an amplification product from the nucleic acid amplification reaction. The present invention is characterized by comprising:

[0069] The sample is preferably a food or drink sample. The food or drink sample may be a sample containing a food or drink composition, a raw material for a food or drink composition, a raw material for a food or drink in the middle of processing, or a processed product thereof (e.g., an extract, a crushed product, a dissolved product), etc. The results obtained by this cashew nut detection method can be used to confirm the accuracy of allergy labeling or to determine whether or not allergy labeling should be made.

[0070] DNA may be extracted from a sample by any method known to those skilled in the art as a nucleic acid extraction method, such as the phenol / chloroform method, cell lysis with a detergent or protease enzyme, physical destruction with glass beads, repeated freezing and thawing, or a combination thereof. In addition, various DNA extraction kits, such as commercially available DNeasy Plant mini Kit, Genomic-tip 20 / G, DNeasy mericon Food Kit (all QIAGEN), and GM quicker 4 (Nippon Gene), may also be used.

[0071] The concentration and purity of the extracted DNA can be assessed by measuring the absorbance at wavelengths of 230, 260, and 280 nm using a spectrophotometer. For example, the concentration of extracted DNA can be calculated using the following formula: DNA concentration (ng / μL) = absorbance at 260 nm × 50

[0072] The degree of purification of DNA is preferably such that the absorbance ratio at 260 / 230 nm is 2.0 or more, and the absorbance ratio at 260 / 280 nm is 1.8 to 2.0, so that the nucleic acid amplification reaction can be carried out satisfactorily.

[0073] Furthermore, the extracted DNA may be subjected to a nucleic acid amplification reaction using a primer set for an endogenous gene shared by plants or animals, and it may be confirmed that an amplified product is obtained.

[0074] The concentration of DNA extracted from the sample can be adjusted appropriately based on the DNA preparation method described in the "Testing Method for Foods Containing Allergens" provided by the Consumer Affairs Agency. The DNA with the adjusted concentration can be used as template DNA. The template DNA is preferably used in an amount of 5 to 500 ng, more preferably 50 ng (this amount is specified in the "Testing Method for Foods Containing Allergens" provided by the Consumer Affairs Agency).

[0075] The nucleic acid amplification reaction may be a nucleic acid amplification reaction using a thermostable polymerase or a nucleic acid amplification reaction using a strand displacement polymerase. The polymerase is preferably a DNA polymerase.

[0076] An example of a nucleic acid amplification reaction using DNA polymerase is the polymerase chain reaction (PCR).

[0077] The PCR method can be carried out based on the usual method described in, for example, Saiki RK, et al., Science, 230:1350-1354 (1985) or Plant Cell Engineering Special Issue, Plant PCR Experimental Protocol, edited by Shimamoto Isao and Sasaki Takuji (1995). PCR conditions (temperature and time for each step of denaturation, annealing, and extension, and number of cycles, etc.) and composition of PCR reaction solution (type of buffer, primer concentration, type and concentration of DNA polymerase, dNTP concentration, magnesium chloride concentration, etc.) can be appropriately selected and set by a person skilled in the art through preliminary experiments, etc., so that PCR amplification products can be obtained with high sensitivity in PCR using the primer set. PCR master mixes and the like in which DNA polymerase, dNTP concentration, magnesium chloride concentration, etc. are almost optimized are commercially available, and these may be used.

[0078] The PCR method may be a qualitative PCR method, in which the cashew nut DNA contained in the DNA extracted from the sample is amplified by PCR using the primer set including primer A and primer B, and then the amplified DNA is separated by electrophoresis and stained to detect the amplified DNA.

[0079] When the primer set including primer A and primer B is used, the presence or absence of an amplification product can be used as an indicator to detect the presence of cashew nuts. If a predetermined amplification product is detected, it can be determined that the sample is contaminated with cashew nuts, and if the amplification product is not detected, it can be determined that the sample is not contaminated with cashew nuts.

[0080] By using the above primer set, cashew nuts can be detected with high sensitivity.

[0081] The primer set preferably further includes a probe, and more preferably includes the probe C. The amplification product can be detected by detecting the binding between the amplification product and the probe. As a detection method using a probe, the TaqMan TM Examples of the method include real-time PCR.

[0082] As the PCR method, a real-time PCR method can be used.

[0083] The real-time PCR method is the intercalator method and TaqMan TM Any method can be used, preferably TaqMan. TM Use the law.

[0084] In the intercalator method, a fluorescent compound (such as SYBR (registered trademark) Green I) is added to the PCR reaction solution, and this binds to the amplified DNA. When this is irradiated with excitation light, it emits fluorescence, and by measuring the intensity of this fluorescence, the amount of amplified product produced can be measured.

[0085] On the other hand, TaqMan TM In this method, a fluorescently labeled probe (TaqMan TMBy including a probe in the PCR reaction solution, the probe binds (hybridizes) to the target sequence in the DNA amplified in the annealing step. In the subsequent extension reaction step, the probe that has bound (hybridized) to the DNA is decomposed by the 5'→3' exonuclease activity of Taq DNA polymerase, and at that time, a fluorescent substance is released from the probe and emits fluorescence. By measuring the intensity of this fluorescence, the amount of amplified product produced can be measured. The device for performing real-time PCR is not particularly limited, and various models that enable real-time PCR, such as ABI PRISM 7900HT (Life Technologies) and LightCycler (registered trademark) 96 (Roche Diagnostics), can be used, and is not particularly limited.

[0086] In the real-time PCR method, the cashew nut DNA contained in the DNA extracted from the sample is amplified by PCR using the primer set, and the amount of PCR amplified product is measured by measuring the fluorescence intensity as described above to obtain an amplification curve. Next, the cycle number (Cq value) at which the fluorescence signal significantly increases is used as an index, or an appropriate threshold (Threshold) of the increase in the amount of fluorescence (ΔRn) is set in the region where the fluorescence signal is exponentially related to the cycle number, and the cycle number (Ct value (Threshold Cycle)) at which the amplification curve intersects with the threshold (Threshold) under appropriate cycle number conditions is used as an index to detect the presence or absence of cashew nuts. That is, if a significant increase in the fluorescence signal is observed or the amplification curve intersects with the threshold under appropriate cycle number conditions, it indicates that cashew nuts are present in the sample, while if no significant increase in the fluorescence signal is observed or the amplification curve does not intersect with the threshold, it indicates that cashew nuts are not present in the sample.

[0087] A qualitative PCR method or a real-time PCR method using the primer set described above, and a qualitative PCR method or a real-time PCR method using the wheat detection primer set, the buckwheat detection primer set, the peanut detection primer set, and / or the walnut detection primer set described in Patent Document 2, can obtain a target amplification product only in the desired sequence while maintaining the desired sensitivity even under the same conditions. Therefore, the cashew nut detection method of the present invention can be simultaneously performed under the same conditions as the wheat detection method described in Patent Document 2, the buckwheat detection method, the peanut detection method, and / or the walnut detection method described in Patent Document 2, and can rapidly and efficiently detect food allergens in a sample.

[0088] Specific embodiments of the present invention will be described in detail below based on examples, but the technical scope of the present invention is not limited to the following examples. EXAMPLES

[0089] Preferred embodiments of the present invention will now be described in detail based on experimental results, but the present invention is not limited to these embodiments.

[0090] <Primer design> Seven forward primers that amplify starting from the 5' base and six reverse primers that amplify starting from the 3' base were designed on the ITS-1 base sequence common to GenBank Accession Nos. AB071690.1 (sequence number 18) and KF664192.1 (sequence number 19), which is DNA containing ITS-1 and ITS-2 of the ribosomal RNA gene derived from the cashew nut plant (Anacardium occidentale) (Table 1).

[0091] Each primer was designed according to the criteria shown in Table 2.

[0092] [Table 1]

[0093] [Table 2]

[0094] Among the forward primers and reverse primers shown in Table 1, priming was possible with 37 combinations, set numbers S1 to S37 shown in Table 3.

[0095] [Table 3]

[0096] The primer sets in Table 3 were evaluated in the following Selection 1 to Selection 5, and a primer set suitable for detecting cashew nuts was selected.

[0097] Selection 1: Selection of primer sets by software Highly rated primer sets were selected using software. Specifically, the 37 primer sets and cashew nut DNA sequence information (GenBank Accession Nos. AB071690.1 (SEQ ID NO: 18) and KF664192.1 (SEQ ID NO: 19)) were input into Primer3 (https: / / bioinfo.ut.ee / primer3-0.4.0 / ) and evaluated according to the criteria shown in the table below.

[0098] [Table 4]

[0099] The primer sets that met the criteria in Table 4 were the 21 pairs shown in the table below.

[0100] [Table 5]

[0101] Selection 2: Selection by PCR with annealing temperature of 64℃ To confirm whether the 21 primer sets shown in Table 5 actually prime with cashew nut DNA, PCR was performed. At that time, the annealing temperature was set to 64°C, which is lower than the target 68°C, to facilitate priming with the template DNA.

[0102] <PCR Conditions 1> The PCR reaction solution contained 1× QuantiTect (registered trademark) Probe PCR Master mix (QIAGEN), 0.2 μM forward primer and reverse primer, and 50 ng of cashew nut-extracted DNA as the template DNA, and was prepared to a total volume of 25 μL and subjected to PCR under the temperature conditions shown in Table 6 below. The cashew nut-extracted DNA was obtained by grinding cashew nuts, extracting them using GM quicker4 (Nippon Gene), and eluting them with TE buffer. The concentration of the obtained cashew nut extract was measured with a spectrophotometer and adjusted to 20 ng / μL with TE buffer.

[0103]

Table 6

[0104] The PCR products obtained by the PCR of <PCR Conditions 1> were analyzed using a microchip electrophoresis apparatus MultiNA (registered trademark) (Shimadzu Corporation). The primer sets that met the criterion that the concentration of the amplification product with the target fragment length was 10 ng / μL or more were 17 sets shown in the table below.

[0105]

Table 7

[0106] Selection 3: Selection by PCR with annealing temperature of 68℃ In all of the real-time PCR methods described in Patent Document 2 for detecting allergens (wheat, buckwheat, peanut), which were developed by the applicant and adopted in the official method, the annealing temperature is 68°C.

[0107] Therefore, to confirm whether the 17 primer sets shown in Table 7 actually prime with cashew nut DNA at the same annealing temperature as theirs, PCR was performed with the annealing temperature set at 68°C.

[0108] <PCR Conditions 2> The PCR reaction solution, similar to PCR Conditions 1, contained 1× QuantiTect® Probe PCR Master mix (QIAGEN), 0.2 μM forward primer and reverse primer, and 50 ng of cashew nut-extracted DNA as the template for PCR, and was prepared to a total volume of 25 μL and subjected to PCR under the temperature conditions shown in Table 8 below.

[0109]

Table 8

[0110] The PCR products amplified under <PCR Conditions 2> were analyzed using a microchip electrophoresis apparatus MultiNA® (Shimadzu Corporation), and the bands were confirmed. The primer sets that met the criterion that the concentration of the amplification product with the target fragment length was 10 ng / μL or more were 15 sets shown in the table below.

[0111]

Table 9

[0112] Selection 4: PCR-based selection using DNA from closely related species of cashew nut plants Among the 15 primer sets shown in Table 9, in order to select those that do not accidentally prime with the DNA of related species of cashew nut plants, PCR was performed using <PCR condition 2> with the DNA of related species as a template. As related species of cashew nut plants, mango, pistachio, pink pepper, and sumac, which are foods in the same Anacardiaceae family as cashew nut plants, are known. In this experiment, 50 ng of the extracted DNA of mango, pistachio, and pink pepper among them was used as a template for PCR. The extraction method was the same as the extraction method of the cashew nut extracted DNA used in the PCR under <PCR condition 1>. The PCR products amplified under <PCR condition 2> were analyzed using a microchip electrophoresis apparatus MultiNA (registered trademark) (Shimadzu Corporation). Among the 15 primer sets, the primer sets that met the criterion of not detecting an amplification product of the target fragment length when using the DNA of related species as a template were 12 sets shown in the following table (see lanes 3, 4, and 5 in Figure 1).

[0113]

Table 10

[0114] Selection 5: PCR-based selection of cashew nut DNA at 5 pg Among the 12 primer sets shown in Table 10, in order to select those that can detect even a trace amount of cashew nut DNA, PCR was performed under <PCR condition 2> using 5 pg and 500 pg of the extracted cashew nut DNA as a template for PCR. All the primer sets shown in Table 10 met the criterion of being able to confirm an amplification product at the target fragment length regardless of whether the amount of the extracted cashew nut DNA was 5 pg or 500 pg (see lanes 1 and 2 in Figure 1).

[0115] A summary of the above five-step selection of primers is shown in the following table.

[0116]

Table 11

[0117] <Probe Design> For the 12 primer sets selected by the above selections 1 to 5, probes were designed according to the criteria shown in the table below, which are generally used when designing probes.

[0118] [Table 12]

[0119] Among the probes that meet the above criteria, the probes combined with the 12 primer sets are shown in the table below. For primer sets S13, S14, and S30, it was not possible to design a probe that meets the criteria. Although not shown in the table below, the combination of primer set S26 and probe P2 (SEQ ID NO: 15), the combination of primer set S27 and probe P2 (SEQ ID NO: 15) or P3 (SEQ ID NO: 16), the combination of primer set S29 and probe P2 (SEQ ID NO: 15), P3 (SEQ ID NO: 16) or P4 (SEQ ID NO: 17), the combination of primer set S32 and probe P3 (SEQ ID NO: 16), and the combination of primer set S35, S36, or S37 and probe P3 (SEQ ID NO: 16) can also be used for real-time PCR.

[0120] [Table 13]

[0121] Evaluation of amplification efficiency and specificity in real-time PCR using DNA from related species Using the above combination of primer set and probe, real-time PCR was performed under the following conditions. The LightCycler (registered trademark) 96 (Roche Diagnostics) was used as the device. To determine the amplification efficiency, the amount of cashew nut extracted DNA in the reaction solution was set to 50 pg, 5 pg, 500 fg, and 50 fg. The formula for calculating the amplification efficiency is (1) below, and it is considered that PCR is optimally performed when the amplification efficiency is 2. The definition of the slope will be described later.

[0122]

number

[0123] <PCR condition 3> The PCR reaction solution contains 1× QuantiTect® Probe PCR Master mix (QIAGEN), 0.2 μM forward primer and reverse primer, 0.1 μM probe, and 50 pg, 5 pg, 500 fg or 50 fg of cashew nut-extracted DNA or 50 ng of Smack-extracted DNA as the template for PCR, and is prepared to a total volume of 25 μL and subjected to PCR under the temperature conditions shown in Table 14 below. The Smack-extracted DNA was extracted by the same method as the cashew nut-extracted DNA.

[0124]

Table 14

[0125] The Cq values measured by real-time PCR using the above primer set and probe combination, and the amplification efficiency calculated from the Cq values and DNA amounts are shown in the following table. Slope refers to the slope of the approximate straight line when the common logarithm of the DNA amount (fg) of each sample is plotted on the horizontal axis and the Cq value is plotted on the vertical axis.

[0126]

Table 15

[0127] In real-time PCR using S25 (F5-R2) / P1 and S26 (F5-R3) / P1 as combinations of primer set and probe, Cq values ​​were detected when the amount of cashew nut DNA used as a template was 500 fg or more. When other combinations of primer set and probe were used, Cq values ​​were detected even when the amount of cashew nut DNA was 50 fg. Among them, real-time PCR using S35 (F7-R4) / P4, S36 (F7-R5) / P4, or S37 (F7-R6) / P4 is more preferable because the Cq value is small, and it was confirmed that the amplification efficiency is closer to 2 when S35 (F7-R4) / P4 or S36 (F7-R5) / P4 is used, which is even more preferable.

[0128] Furthermore, no amplification product of the desired fragment length was obtained in the reaction solution containing 50 ng of sumac-extracted DNA, regardless of which combination of primer set and probe was used.

Claims

1. A primer set for detecting cashew nuts, (A1) base sequence A1, (A2) a base sequence A2 having an identity of 80% or more but less than 100% with the base sequence A1, and a partial base sequence of NA consecutive bases (NA is an integer of 1 or more) from the 3'-terminal base being identical to a partial base sequence of NA consecutive bases from the 3'-terminal base of the base sequence A1; and (A3) A base sequence A3, which is a partial base sequence of 8 or more consecutive bases from the 3'-terminal base of the base sequence A1 or A2. A primer A comprising an oligonucleotide comprising at its 3' end a base sequence A selected from the following: (B1) base sequence B1, (B2) a base sequence B2 having an identity of 80% or more but less than 100% with the base sequence B1, and a partial base sequence of N B consecutive bases (N B is an integer of 1 or more) from the 3'-terminal base being identical to a partial base sequence of N B consecutive bases from the 3'-terminal base of the base sequence B1; and (B3) A base sequence B3 which is a partial base sequence of 8 or more consecutive bases from the 3'-terminal base of the base sequence B1 or B2. Primer B comprising an oligonucleotide containing at its 3' end a base sequence B selected from Including, The base sequence A1 and the base sequence B1 are the following combination: (S13) The base sequence A1 is a base sequence shown in SEQ ID NO: 3, and the base sequence B1 is a base sequence shown in SEQ ID NO:

8. (S14) The base sequence A1 is a base sequence shown in SEQ ID NO: 3, and the base sequence B1 is a base sequence shown in SEQ ID NO:

9. (S25) The base sequence A1 is a base sequence shown in SEQ ID NO: 5, and the base sequence B1 is a base sequence shown in SEQ ID NO:

9. (S26) The base sequence A1 is a base sequence shown in SEQ ID NO: 5, and the base sequence B1 is a base sequence shown in SEQ ID NO:

10. (S27) The base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO:

11. (S29) The base sequence A1 is the base sequence shown in SEQ ID NO: 5, and the base sequence B1 is the base sequence shown in SEQ ID NO:

13. (S30) The base sequence A1 is a base sequence shown in SEQ ID NO: 6, and the base sequence B1 is a base sequence shown in SEQ ID NO: 9, (S31) The base sequence A1 is a base sequence shown in SEQ ID NO: 6, and the base sequence B1 is a base sequence shown in SEQ ID NO:

10. (S32) The base sequence A1 is a base sequence shown in SEQ ID NO: 6, and the base sequence B1 is a base sequence shown in SEQ ID NO:

11. (S35) The base sequence A1 is the base sequence shown in SEQ ID NO: 7, and the base sequence B1 is the base sequence shown in SEQ ID NO:

11. (S36) The base sequence A1 is a base sequence shown in SEQ ID NO: 7, and the base sequence B1 is a base sequence shown in SEQ ID NO:

12. (S37) The base sequence A1 is a base sequence shown in SEQ ID NO: 7, and the base sequence B1 is a base sequence shown in SEQ ID NO:

13. Either Primer set.

2. The primer set according to claim 1, wherein the base sequence A1 and the base sequence B1 are the combination (S25), (S26), (S27), (S29), (S31), (S32), (S35), (S36) or (S37).

3. The primer set according to claim 2 , wherein the base sequence A1 and the base sequence B1 are the combination (S35) or (S36).

4. (C1) base sequence C1, (C2) a base sequence C2 having an identity of 80% or more but less than 100% with the base sequence C1, and a partial base sequence of a number NC of consecutive bases (NC is an integer of 3 or more) being identical to a partial base sequence of the number NC of consecutive bases in the base sequence C1; (C3) a base sequence C3 which is a partial base sequence of 8 or more consecutive bases of the base sequence C1 or C2; and (C4) a base sequence C4 complementary to the base sequence C1, C2 or C3 The method further comprises the step of: When the base sequence A1 and the base sequence B1 are the combination (S25), the base sequence C1 is the base sequence shown in SEQ ID NO: 14, When the base sequence A1 and the base sequence B1 are the combination (S26), the base sequence C1 is the base sequence shown in SEQ ID NO: 14 or 15, When the base sequence A1 and the base sequence B1 are the combination (S27), the base sequence C1 is a base sequence shown in SEQ ID NO: 14, 15 or 16, When the base sequence A1 and the base sequence B1 are the combination (S29), the base sequence C1 is a base sequence shown in SEQ ID NO: 14, 15, 16 or 17, When the base sequence A1 and the base sequence B1 are the combination (S31), the base sequence C1 is the base sequence shown in SEQ ID NO: 15, when the base sequence A1 and the base sequence B1 are the combination (S32), the base sequence C1 is the base sequence shown in SEQ ID NO: 15 or 16, When the base sequence A1 and the base sequence B1 are the combination (S35), (S36) or (S37), the base sequence C1 is the base sequence shown in SEQ ID NO: 16 or 17. The primer set according to claim 2.

5. The primer set according to claim 4, wherein the base sequence A1 and the base sequence B1 are the combination (S35), (S36) or (S37), and the base sequence C1 is the base sequence shown in SEQ ID NO: 16 or 17.

6. The primer set according to claim 5, wherein the base sequence A1 and the base sequence B1 are the combination (S35) or (S36), and the base sequence C1 is the base sequence shown in SEQ ID NO:

17.

7. 1. A method for detecting cashew nuts in a sample, comprising: carrying out a nucleic acid amplification reaction using DNA derived from the sample as a template and the primer set according to claim 1; and Detecting an amplification product from the nucleic acid amplification reaction. The method includes:

8. 1. A method for detecting cashew nuts in a sample, comprising: carrying out a nucleic acid amplification reaction using DNA derived from the sample as a template and the primer set according to claim 4; and Detecting the binding between the amplification product of the nucleic acid amplification reaction and the probe C. The method includes:

9. The method according to claim 7 or 8, wherein the sample is a food or beverage sample.

Citation Information

Patent Citations

  • Peanut detection method and kit by PCR

    JP2016101142A

  • Primer, and method for detecting tree nut

    JP2016187329A